Stock Research for CYAN


Featured Broker: Ally Invest

Get the due diligence for another stock.


CYAN Stock Chart & Research Data

The CYAN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CYAN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


CYAN Due diligence Resources & Stock Charts

The CYAN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CYAN Detailed Price Forecast - CNN Money CNN View CYAN Detailed Summary - Google Finance
Yahoo View CYAN Detailed Summary - Yahoo! Finance Zacks View CYAN Stock Research & Analysis -

Stock Analysis

TradeIdeas View CYAN Trends & Analysis - Trade-Ideas Barrons View CYAN Major Holders - Barrons
NASDAQ View CYAN Call Transcripts - NASDAQ Seeking View CYAN Breaking News & Analysis - Seeking Alpha
Spotlight View CYAN Annual Report - OTC Report View CYAN OTC Short Report -
TradeKing View CYAN Fundamentals - TradeKing Charts View CYAN SEC Filings - Bar Chart
WSJ View Historical Prices for CYAN - The WSJ Morningstar View Performance/Total Return for CYAN - Morningstar
MarketWatch View the Analyst Estimates for CYAN - MarketWatch CNBC View the Earnings History for CYAN - CNBC
StockMarketWatch View the CYAN Earnings - StockMarketWatch MacroAxis View CYAN Buy or Sell Recommendations - MacroAxis
Bullish View the CYAN Bullish Patterns - American Bulls Short Pains View CYAN Short Pain Metrics -

Social Media Mentions

StockTwits View CYAN Stock Mentions - StockTwits PennyStocks View CYAN Stock Mentions - PennyStockTweets
Twitter View CYAN Stock Mentions - Twitter Invest Hub View CYAN Investment Forum News - Investor Hub
Yahoo View CYAN Stock Mentions - Yahoo! Message Board Seeking Alpha View CYAN Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for CYAN - Insider Cow View Insider Transactions for CYAN - Insider Cow
CNBC View CYAN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CYAN - OTC Markets
Yahoo View Insider Transactions for CYAN - Yahoo! Finance NASDAQ View Institutional Holdings for CYAN - NASDAQ

Stock Charts

FinViz View CYAN Stock Insight & Charts - StockCharts View CYAN Investment Charts -
BarChart View CYAN Stock Overview & Charts - BarChart Trading View View CYAN User Generated Charts - Trading View

Latest Financial News for CYAN

Cyanotech® Corporation Signs Asset Purchase Agreement for Cellana’s Kona Demonstration Facility
Posted on Friday September 07, 2018

Cyanotech® Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, is pleased to announce that it has signed an Asset Purchase Agreement with Cellana LLC to acquire a six-acre production and research facility, known as the Kona Demonstration Facility (KDF), located adjacent to Cyanotech’s existing 90-acre site at the Natural Energy Laboratory of Hawaii Authority (NELHA). The acquisition includes all existing equipment and other assets necessary to operate the facility.

Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2019
Posted on Monday August 13, 2018

Cyanotech Corporation , a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the first quarter of fiscal year 2019, ended June 30, 2018.

Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2018
Posted on Friday June 15, 2018

Cyanotech Corporation , a world leader in microalgae-based, high-value nutrition and health products, announced financial results for the fourth quarter and fiscal year 2018, ended March 31, 2018.

Wired News – Aimmune Therapeutics’ Peanut Allergy Drug AR101 Met Primary Endpoint in Pivotal Phase-3 Clinical Trial
Posted on Thursday February 22, 2018

Stock Monitor: Cyanotech Post Earnings Reporting LONDON, UK / ACCESSWIRE / February 22, 2018 / has just released a free research report on Aimmune Therapeutics, Inc. (NASDAQ: AIMT ...

Stock Market & Investing Books

Enter a stock symbol to view the stock details.